Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise:
Dr Ali is a board-certified cardiologist specialising in interventional and structural cardiology atSt Francis Hospital and Heart Centerin Roslyn, New York. Ziad is an internationally renowned expert in complex high-risk indicated percutaneous coronary interventions (CHIP) including the treatment of chronic total occlusions (CTO) where the arteries in the heart become completely blocked. … View more
Research Area(s) / Expertise: Job title: Medical Director and Director of the Department of Cardiothoracic and Vascular Surgery
Professor Volkmar Falk is the Medical Director and Director of the Department of Cardiothoracic and Vascular Surgery of the German Heart Center Berlin, Chair of the Division of Cardiovascular Surgery at the Charité Berlin and Professor for Translational Cardiovascular Technologies at the ETH, Zurich. After successfully completing medical school and his doctorate at the University of Bonn, he… View more
A Peek into the Future
Author(s): Nicolas M Van Mieghem , Peter Lüdike , Philipp Lurz , et al Start date: Mar 18, 2021

Intervention
Foreword

Article

Author(s): Simon Kennon Added: 3 years ago
This issue of the journal – as it often does – reflects areas of interventional cardiology at different stages of maturity. The majority of patients undergoing percutaneous coronary intervention do so in the context of acute coronary syndromes and the cardiovascular community has been striving for decades to achieve the perfect balance between preventing thrombus generation on the one hand and… View more

Intervention
Escalation & De-Escalation With MCS: A Practical Approach
Author(s): Nicolas M Van Mieghem , Federico Pappalardo , Divaka Perera , et al Added: 3 months ago
This session provides practical treatment strategies and management of MCS in Cardiogenic Shock: starting with a review of the different phenotype of cardiogenic shock stages and the timing of the treatment of vasopressor, Impella and ECMO as standalone or combined. View more

Intervention
Job title: MD
Prof Francesco Bedogni is the Director of the Clinical Cardiology, Interventional Cardiology, and Coronary Intensive Care Units (UTIC) at the IRCCS Policlinico San Donato, Milan, IT. He has authored over 320 scientific articles and abstracts, which have achieved significant bibliometric recognition. His contributions have appeared in prestigious journals such as Circulation, Journal of the… View more
ACC 2020 Wrap Up: An Analysis of the Late-breaking Trials
Author(s): Nicolas M Van Mieghem , Joost Daemen Start date: Apr 03, 2020
Prof Nicolas van Mieghem & Dr Joost Daemen (Erasmus MC, Rotterdam, NL) review and discuss the results of the late-breaking trials of ACC 2020. Streaming live on Radcliffe Cardiology. View more

Anticoagulation
Roxana Mehran
Research Area(s) / Expertise: Job title: Professor of Medicine, Cardiology and Professor of Population Health Science and Policy
Roxana Mehran is Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past 5 years, she has led the development of a… View more
Johnathan Yap
Research Area(s) / Expertise:

Coronary Interventions

Coronary Physiology

 Job title: Consultant Cardiologist
Clinical Associate Professor Jonathan Yap is a Consultant with the Department of Cardiology at NHCS. His subspeciality interest is in interventional cardiology, pulmonary hypertension and structural heart disease including transcatheter aortic valve interventions (TAVI) for aortic stenosis. He spent a year in the United States performing his advanced fellowship in structural heart interventions… View more
Expanding Vascular Access Options in TAVI
Author(s): Dr Won-Keun Kim Start date: Oct 23, 2018
Transcatheter aortic valve implantation (TAVI) has emerged to be a viable treatment option for patients suffering from Severe Aortic Stenosis. The transfemoral approach is the most common access route for TAVI and associated with most favourable clinical outcomes. However, with a population with increasingly complex vasculature, the incidence of vascular complications in TAVI remains high… View more

Vascular Disease and Surgery

Intervention